{"title": "Immunstimulation zur Pr\u00e4vention und Therapie von akuten Luftwegsinfektionen", "author": "PHC Primary; Hospital Care; Martina Germann; Anina Hilfiker; Benedikt M Huber; Claudia Rosamilia; Tanja Grandinetti; Bernhard Wingeier; Gisela Etter; Peter Christiaan Carp; Jeanette Kurath; Werner C Albrich; Philip Tarr", "url": "https://phc.swisshealthweb.ch/de/article/doi/phc-d.2019.10139", "hostname": "swisshealthweb.ch", "description": "Jedes Jahr im Herbst, wenn die \u00abSchnupfensaison\u00bb beginnt, werden wir von neuem mit einer grossen Zahl von Luftwegsinfektionen konfrontiert. Viele Patient/-innen fragen in diesem Zusammenhang nach M\u00f6glichkeiten, wie man Luftwegsinfektionen durch St\u00e4rkung des Immunsystems vorbeugen oder behandeln kann. Zu einigen Produkten mit immunstimulierender Wirkung gibt es solide Daten.", "sitename": "Martina Germann,Anina Hilfiker,Benedikt M. Huber,Claudia Rosamilia,Tanja Grandinetti,Bernhard Wingeier,Gisela Etter,Peter Christiaan Carp,Jeanette Kurath,Werner C. Albrich,Philip Tarr", "date": "2019-11-06", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "\u2013 Del-Rio-Navarro B, Espinosa-Rosales FJ, Flenady V, Sienra-Monge JJL. Cochrane Review: Immunostimulants for preventing respiratory tract infections in children. Evid.-Based Child Health, Bd. 7, Nr. 2, S. 629\u2013717:2012.\n\u2013 Shah SA, Sander S, White M, Rinaldi M, Coleman CJ. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis, Bd. 7, Nr. 7, S. 473\u2013480:2007.\n\u2013 Karsch-V\u00f6lk M, Barrett B, Linde K. Echinacea for Preventing and Treating the Common Cold. JAMA, Bd. 313, Nr. 6, S. 618\u2013619.2015.\n\u2013 Autier P, Mullie P, Macacu A, Dragomir M, Boniol M, Coppens K. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endo, Bd. 5, Nr. 12, S. 986\u20131004:2017.\nLiteratur\n1 Linder JA. Comparative Effectiveness of Three Anxiolytics for Acute Respiratory Infections: Antibiotics, C-Reactive Protein Point-of-Care Testing, and Improved Communication. J Gen Intern Med. Bd. 30, Nr.4,S.387\u20139:2015.\n2 Hofmann Y, et al. Behandlung der Streptokokken-Angina \u2013 Zeit f\u00fcr einen Paradigmenwechsel. EMH Media, Bd. 19, Nr. 2930, S. 481\u20138:2019.\n3 Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev, Bd. 8, Art. CD001831:2012.\n4 Venekamp RP, et al. Systemic corticosteroids for acute sinusitis. Cochrane Database Syst Rev, Bd. 3, Art. CD008115:2014.\n5 Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev, Bd. 12, Art. CD005149:2013.\n6 Hendley LO, Abbott RD, Beasley PP, Gwaltney JM. Effect of Inhalation of Hot Humidified Air on Experimental Rhinovirus Infection. JAMA. Bd. 271, Nr. 14, S. 1112\u20133:1994.\n7 Forstall GJ, Macknin ML, Yen-Lieberman BR, VanderBrug Medendorp S. Effect of Inhaling Heated Vapor on Symptoms of the Common Cold. JAMA. Bd. 271, Nr. 14, S. 1109\u2013111:1994.\n8 Monto AS. The Common Cold: Cold Water on Hot News. JAMA. Bd. 271, Nr. 14, S. 1122\u20134:1994.\n9 Singh M. Heated, humidified air for the common cold. Cochrane Database Syst Rev, Bd. 5, Art. CD001728:2011.\n10 Francino MP. Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances. Front Microbiol, Bd. 6, Nr. 1543.2016.\n11 Oldenburg CE, u.a. Gut Resistome After Oral Antibiotics in Preschool Children in Burkina Faso: A Randomized Controlled Trial. Clin Infect Dis. Art. ciz455:2019.\n12 Heikkinen T, J\u00e4rvinen A. The common cold. The Lancet, Bd. 361, Nr. 9351, S. 51\u20139: 2003.\n13 Rovers MM, Balemans WA, Sanders EA, van der Ent CK, Zielhuis GA, Schilder AG. Persistence of upper respiratory tract infections in a cohort followes from childhood to adulthood. Family Practice, Bd. 23, Nr. 3, S. 286\u201390:2006.\n14 Del-Rio-Navarro B, Espinosa-Rosales FJ, Flenady V, Sienra-Monge JJL. Cochrane Review: Immunostimulants for preventing respiratory tract infections in children. Evid.-Based Child Health, Bd. 7, Nr. 2, S. 629\u2013717:2012.\n15 Sullivan JE, Farrar HC. Clinical Report \u2013 Fever and Antipyretic Use in Children. Pediatrics, Bd. 127, Nr. 3, S. 580\u20137:2011.\n16 Richardson M, Purssell E. Who\u2019s afraid of fever? Arch Dis Child, Bd. 100, Nr. 9, S. 818\u201320:2015.\n17 Graham NM, Burrell CJ, Douglas RM, Debelle P, Davies L. Adverse Effects of Aspirin, Acetaminophen, and Ibuprofen on Immune Function, Viral Shedding, and Clinical Status in Rhinovirus-Infected Volunteers. J Infect Dis, Bd. 162, Nr. 6, S. 1277\u201382:1990.\n18 Brandts CH, Ndjav\u00e9 M, Graninger W, Kremsner PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet. Bd. 350, Nr. 9079, S. 704\u20139:1997.\n19 Prymula R, Siegrist C-A, Chlibek R, Zemlickova H, Vackova M, Smetana J, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet. Bd. 374, Nr. 9698, S. 1339\u201350:2009.\n20 Bioforce. A. Vogel: Pflanzliches Arzneimittel Echinaforce\u00ae\nTabletten. Bioforce, 30-Aug-2018. [Online]. Verf\u00fcgbar unter:\n[https://www.bioforce.ch/de/produkte/arzneimittel/echinaforce_tabletten.php?_ga=2.29882296.605880013.1553503140-1690005440.1548071265](https://www.bioforce.ch/de/produkte/arzneimittel/echinaforce_tabletten.php?_ga=2.29882296.605880013.1553503140-1690005440.1548071265)\n. [Zugegriffen: 25-M\u00e4rz-2019].\n21 Pleschka S, Stein M, Schoop R, Hudson JB. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian Influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virology Journal. Bd. 6, Nr. 197:2009.\n22 Sharma M, Anderson SA, Schoop R, Hudson JB. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Research. Bd. 83, Nr. 2, S. 165\u201370:2009.\n23 Jawad M, Schoop R, Suter A, Klein P, Eccles R. Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement Alternat Med. Bd. 2012, Nr. 841315:2012.\n24 Manayi A, Vazirian M, und Saeidnia S. Echinacea purpurea: Pharmacology, phytochemistry and analysis methods. Pharmacogn Rev, Bd. 9, Nr. 17, S. 63\u201372:2015.\n25 Barrett B, et al. Echinacea for Treating the Common Cold. Ann Intern Med. Bd. 153, Nr. 12, S. 769\u201377:2010.\n26 Rau\u0161 K, Pleschka S, Klein P, Schoop R, Fisher P. Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial. Curr Ther Res Clin Exp. Bd. 77, S. 66\u201372:2015.\n27 Karsch-V\u00f6lk M, Barrett B, Linde K. Echinacea for Preventing and Treating the Common Cold. JAMA. Bd. 313, Nr. 6, S. 618\u20139:2015.\n28 Shah SA, Sander S, White M, Rinaldi M, Coleman CJ. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis. Bd. 7, Nr. 7, S. 473\u201380, Juli 2007.\n29 Taylor JA, Weber W, Standish L, McGann M, Calabrese C. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA. Bd. 290, Nr. 21, S. 2824\u201330:2003.\n30 Koordinationsstelle Forschung am Menschen. Wirksamkeit und Sicherheit von Echinacea Produkten bei Erk\u00e4ltungen. Kofam: Studienregister SNCTP, 13-Mai-2019. [Online]. Verf\u00fcgbar unter:\n[https://www.kofam.ch/de/studienportal/studie/44496/](https://www.kofam.ch/de/studienportal/studie/44496/)\n. [Zugegriffen: 13-Mai-2019].\n31 Ogal M, Klein P, Schoop R. Echinacea for the Prevention of Respiratory Tract Infections in Children 4\u201312 years: A Randomized, Blind and Controlled Study. Swiss Med Wkly. Bd. 148, Nr. Supplementum 228 \u201cJoint Annual Meeting: Swiss Society of Paediatrics, Swiss Society of Paediatric Surgery and Swiss Society of Child and Adolescent Psychiatriy and Psychotherapy\u201d (Lausanne, 24./25. Mai 2018), S. 6, Mai 2018. [Online]. Verf\u00fcgbar unter:\n[https://smw.ch/ fileadmin/content/supplements/SMW_Suppl_228.pdf](https://smw.ch/fileadmin/content/supplements/SMW_Suppl_228.pdf)\n. [Zugegriffen: 19-August-2019].\n32 Sangvai S, Chianese J, Morone N, Bogen DL, Voigt L, Shaikh N. Can an Herbal Preparation of Echinacea, Propolis, and Vitamin C Reduce Respiratory Illnesses in Children? Arch Pediatr Adolesc Med. Bd. 158, Nr. 3, S. 222\u20134:2004.\n33 Schwabe Pharma AG. Pflanzenkraft statt Antibiotika. o.D. [Online]. Verf\u00fcgbar unter:\n[https://www.umckaloabo.ch/de/umckaloabo/pflanzenkraft-statt-antibiotika/](https://www.umckaloabo.ch/de/umckaloabo/pflanzenkraft-statt-antibiotika/)\n. [Zugegriffen: 22-Apr-2019].\n34 Roth M, Fang L, Tamm M, Stolz D. Pelargonium sidoides radix extract EPs 7630 reduces rhinovirus infection through modulation of viral binding proteins on human bronchial epithelial cells. PLoS One. Bd. 14, Nr. 2, Art. e0210702:2019.\n35 Michaelis M, Doerr HW, Cinatl Jr J. Investigation of the influence of EPs\u00ae 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. Bd. 18, Nr. 5, S. 384\u20136:2011.\n36 Timmer A, G\u00fcnther J, Motschall E, R\u00fccker G, Antes G, Kern WV. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev, Bd. 10, Art. CD006323, Okt. 2013.\n37 G\u00fcnther J, Hinneburg I. Pelargonium bei Atemwegsinfekten. Pharmazeutische Zeitung, Berlin, 22-Feb-2016. [Online]. Verf\u00fcgbar unter:\n[https://www.pharmazeutische-zeitung.de/ausgabe-082016/pelargonium-bei-atemwegsinfekten/](https://www.pharmazeutische-zeitung.de/ausgabe-082016/pelargonium-bei-atemwegsinfekten/)\n. [Zugegriffen: 13-Mai-2019].\n38 Tahan F, Yaman M. Can the Pelargonium sidoides root extract EPs\u00ae 7630 prevent asthma attacks during viral infections of the upper respiratory tract in children? Phytomedicine. Bd. 20, Nr. 2, S. 148\u2013150:2013.\n39 Stolz D, et al. Diagnosis, Prevention and Treatment of Stable COPD and Acute Exacerbations of COPD: The Swiss Recommendations 2018. Respiration. Bd. 96, Nr. 4, S. 382\u201398:2018.\n40 Matthys H, Pliskevich DA, Bondarchuk O, Malek FA, Tribanek M, Kieser M. Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD. Respir Med. Bd. 107, Nr. 5, S. 691\u2013701:2013.\n41 Matthys H, Funk P. Pelargonium sidoides preparation EPs 7630 in COPD: health-related quality-of-life and other patient-reported outcomes in adults receiving add-on therapy. Curr Med Res Opin. Bd. 34, Nr. 7, S. 1245\u20131251.2018.\n42 Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status an ill health: a systematic review. Lancet Diabetes Endo. Bd. 2, Nr. 1, S. 76\u201389:2014.\n43 Bundesamt f\u00fcr Gesundheit BAG. Vitamin-D-Mangel: Datenlage, Sicherheit und Empfehlungen f\u00fcr die Schweizer Bev\u00f6lkerung. Bundesamt f\u00fcr Gesundheit, Bern, M\u00e4rz 2012. [Online]. Verf\u00fcgbar unter:\n[https://www.eek.admin.ch/dam/eek/de/dokumente/publikation-und-dokumentation/ausfuehrlicher-expertenbericht-vitamin-d-mangel.pdf.download.pdf/ Vitamin_D_Bericht.pdf](https://www.eek.admin.ch/dam/eek/de/dokumente/publikation-und-dokumentation/ausfuehrlicher-expertenbericht-vitamin-d-mangel.pdf.download.pdf/ Vitamin_D_Bericht.pdf)\n[Zugegriffen: 19-August-2019].\n44 Bischoff-Ferrari HA, et al. Empfehlungen der Eidgen\u00f6ssischen Ern\u00e4hrungskommission zur Vitamin-D-Zufuhr f\u00fcr die Schweizer Bev\u00f6lkerung. Schweiz Med Forum. Bd. 12, Nr. 40, S. 775\u2013778, Jan. 2012.\n45 Coussens AK, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. PNAS, Bd. 109, Nr. 38, S. 15449\u201315454. 2012.\n46 Wu HX, Xiong XF, Zhu M, Wei J, Zhuo KQ, Cheng DY. Effects of vitamin D supplementation on the outcomes of patients with pulmonary tuberculosis: a systematic review and meta-analysis. BMC Pulm Med. Bd. 18, Nr. 1, S. 108:2018.\n47 Manson JE, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med. Bd. 380, Nr. 1, S. 33\u201344:2019.\n48 Autier P, Mullie P, Macacu A, Dragomir M, Boniol M, Coppens K. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endo, Bd. 5, Nr. 12, S. 986\u20131004:2017.\n49 Mandlik R, Chiplonkar S, Kajale N, Khadilkar V, Khadilkar A. Infection Status of Rural Schoolchildren and its Relationship with Vitamin D Concentrations. Indian J Pediatr. Bd. 86, Nr. 8, S. 675\u2013680:2019.\n50 Bose S, et al. Vitamin D Status Modifies the Response to Indoor Particulate Matter in Obese Urban Children with Asthma. J Allergy Clin Immunol Pract. Bd. 7, Nr. 6, S. 1815\u20131822:2019.\n51 Vo P, et al. Vitamin D Status at the Time of Hospitalization for Bronchiolitis and Its Association with Disease Severity. J Pediatr. Bd. 203, S. 416\u2013422:2018.\n52 Martineau AR, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. Bd. 356, Art. i6583:2017.\n53 Wang M, et al. Association between vitamin D status and asthma control: A meta-analysis of randomized trials. Respir Med, Bd. 150, S. 85\u201394:2019.\n54 Vuichard Gysin D, Dao D, Gysin CM, Lytvyn L, Loeb MB. Effect of Vitamin D3 Supplementation on Respiratory Tract Infections in Healthy Individuals: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One, Bd. 11, Nr. 9, Art. e0162996:2016.\n55 Murdoch DR, et al. Effect of Vitamin D3 Supplementation on Upper Respiratory Tract Infections in Healthy Adults: The VIDARIS Randomized Controlled Trial. JAMA. Bd. 308, Nr. 13, S. 1333\u20131339:2012.\n56 Lehouck A, et al. High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease: A Randomized Trial. Ann Intern Med. Bd. 156, Nr. 2, S. 105\u2013114:2012.\n57 Science M, Johnstone J, Roth DE, Guyatt G, Loeb MB. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials. CMAJ. Bd. 184, Nr. 10, S. E551\u2013E561:2012.\n58 Hemil\u00e4 H, Petrus EJ, Fitzgerald JT, Prasad A. Zinc acetate lozenges for treating the common cold: an individual patient data meta-analysis. Br J Clin Pharmacol. Bd. 82, Nr. 5, S. 1393\u20131398:2016.\n59 Hemil\u00e4 H, Fitzgerald JT, Petrus EJ, Prasad A. Zinc Acetate Lozenges May Improve the Recovery Rate of Common Cold Patients: An Individual Patient Data Meta-Analysis. OFID, Bd. 4, Nr. 2, Art. ofx059:2017.\n60 Eby III GA. Zinc for colds? Yes, but don\u2019t swallow whole! J Fam Pract.Bd. 61, Nr. 1, Author Reply S. 9\u201310:2012.\n61 Eby III GA. Zinc lozenges as cure for the common cold \u2013 a review and hypothesis. Med Hypothesis. Bd. 74, Nr. 3, S. 482\u201392:2010.\n62 Schlatter C. Zink zur Behandlung und Prophylaxe von Erk\u00e4ltungen. Pharmaceutical Care Research Group, Universit\u00e4t Basel, i.m@il Offizin 22:2013.\n63 Esposito S, Soto-Martinez ME, Feleszko W, Jones MH, Shen K-L, Schaad UB. Nonspecific immunomodulators for revurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistiv and clinical evidence. Curr Opin Allergy Clin Immunol. Bd. 18, Nr. 3, S. 198\u2013209:2018.\n64 Schaad UB. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr. Bd. 6, Nr. 1, S. 5\u201312:2010.\n65 Collet JP, Shapiro S, Ernst P, Renzi P, Ducruet T, Robinson A. Effects of an lmmunostimulating Aqent on Acute Exacerbations and Hospitalizations In Patients with Chronic Obstructive Pulmonary Disease: The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. Am J Respir Crit Care Med. Bd. 156, Nr. 6, S. 1719\u201324:1997.\n66 Sol\u00e8r M, M\u00fctterlein R, Cozma G. Double-Blind Study of OM-85 in Patients with Chronic Bronchitis or Mild Chronic Obstructive Pulmonary Disease. Respiration. Bd. 74, Nr. 1, S. 26\u201332:2006.\n67 Hurst JR, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. Bd. 363, Nr. 12, S. 1128\u20131138, Sep. 2010.\n68 Sprenkle MD, Niewoehner DE, MacDonald R, Rutks I, Wilt TJ. Clinical Efficacy of OM-85 BV in COPD and Chronic Bronchitis: A Systematic Review. COPD, Bd. 2, Nr. 1, S. 167\u201375:2005.\n69 Pan L, Jiang XG, Guo J, Tian Y, Liu CT. Effects of OM-85 BV in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. J Clin Pharmacol. Bd. 55, Nr. 10, S. 1086\u20131092, Okt. 2015.\n70 European Medicines Agency. Bacterial lysate medicines for respiratory conditions to be used only for prevention of recurrent infections. European Medicines Agency: Science, Medicines, Health, 28-Juni-2019. [Online]. Verf\u00fcgbar unter:\n[https://www.ema.europa.eu/en/news/bacterial-lysate-medicines-respiratory-conditions-be-used-only-prevention-recurrent-infections](https://www.ema.europa.eu/en/news/bacterial-lysate-medicines-respiratory-conditions-be-used-only-prevention-recurrent-infections)\n. [Zugegriffen: 15-Juli-2019].\n71 Barrett B, et al. Meditation or exercise for Preventing Acute Respiratory Infection: A Randomized Controlled Trial. Ann Fam Med. Bd. 10, Nr. 4, S. 337\u2013346:2012.\n72 Kostka T, Berthouze SE, Lacour JR, Bonnefoy M. The symptomatology of upper respiratory tract infections and exercise in elderly people. Med Sci Sports Exerc, Bd. 32, Nr. 1, S. 46\u201351:2000.\n73 Kostka T, Drygas W, Jegier A, Praczko K. Physical activity and upper respiratory tract infections. Int J Sports Med, Bd. 29, Nr. 2, S. 158\u2013162:2008.\n74 Kostka T, Praczko K. Interrelationship between physical activity, symptomatology of upper respiratory tract infections, and depression in elderly people. Gerontology, Bd. 53, Nr. 4, S. 187\u2013193:2007.\n75 \u00c7ilo\u011flu F. The effect of exercise on salivary IgA levels and the incidence of upper respiratory tract infections in postmenopausal women. Tr-ENT, Bd. 15, Nr. 5\u20136, S. 112\u2013116:2005.\n76 Matthews CE, Ockene IS, Freedson PS, Rosal MC, Merriam PA, Hebert JR. Moderate to vigorous physical activity and risk of upper-respiratory tract infection. Med Sci Sports Exerc. Bd. 34, Nr. 8, S. 1242\u20131248:2002.\n77 Davison G, Kehaya C, Jones AW. Nutritional and Physical Activity Interventions to Improve Immunity. Am J Lifestyle Med. Bd. 10, Nr. 3, S. 152\u2013169:2016.\n78 Obasi CN, et al. Advantage of meditation over exercise in reducing cold and flu illness is related to improved function and quality of life. Influenza Other Respir Viruses. Bd. 7, Nr. 6, S. 938\u2013944:2013.\n79 Nieman DC, Henson DA, Austin MD, Sha W. Upper respiratory tract infection is reduced in physically fit and active adults. Br J Sports Med. Bd. 45, Nr. 12, S. 987\u2013992:2011.\n80 Chubak J, et al. Moderate-intensity exercise reduces the incidence of colds among postmenopausal women. Am J Med. Bd. 119, Nr. 11, S. 937\u2013942:2006.\n81 Nieman DC, et al. Immune response to exercise training and/or energy restriction in obese women. Med Sci Sports Exerc. Bd. 30, Nr. 5, S. 679\u2013686:1998.\n82 Weidner T, Schurr T. Effect of exercise on upper respiratory tract infection in sedentary subjects. BR J Sports Med. Bd. 37, Nr. 4, S. 304\u2013306:2003.\n83 Fondell E, et al. Physical Activity, Stress, and Self-Reported Upper Respiratory Tract Infection. Med Sci Sports Exerc. Bd. 43, Nr. 2, S. 272\u2013279, Feb. 2011.\n84 Spence L, et al. Incidence, Etiology, and Symptomatology of Upper Respiratory Illness in Elite Athletes. Med Sci Sports Exerc. Bd. 39, Nr. 4, S. 577\u2013586:2007.\n85 Moreira A, Delgado L, Moreira P, Haahtela T. Does exercise increase the risk of upper respiratory tract infections? Br Med Bull. Bd. 90, Nr. 1, S. 111\u2013131:2009.\n86 Grande AJ, Keogh J, Hoffmann TC, Beller EM, Del Mar CB. Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections (Review). Cochrane Database Syst Rev, Bd. 6, Art. CD010596:2015.\n87 Cohen S, Doyle WJ, Alper CM, Janicki-Deverts D, Turner RB. Sleep Habits and Susceptibility to the Common Cold. Arch Intern Med. Bd. 169, Nr. 1, S. 62\u201367:2009.\n88 Satomura K, et al. Prevention of Upper Respiratory Tract Infections by Gargling: A Randomized Trial. Am J Prev Med. Bd. 29, Nr. 4, S. 302\u2013307:2005.\n89 Goodall EC, et al. Vitamin D3 and gargling for the prevention of upper respiratory tract infections: a randomized controlled trial. BMC Infect Dis. Bd. 14, Nr. 1, S. 273:2014.\n90 Jefferson T, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ. Bd. 339, Art. b3675:2009.\n91 Turner RB, Fuls JL, Rodgers ND, Goldfarb HB, Lockhart LK, Aust LB. A Randomized Trial of the Efficacy of Hand Disinfection for Prevention of Rhinovirus Infection. Clin Infect Dis. Bd. 54, Nr. 10, S. 1422\u20131426:2012.\n92 \u0160lapak I, Skoup\u00e1 J, Strnad P, Horn\u00edk P. Efficacy of Isotonic Nasal Wash (Seawater) in the Treatment and Prevention of Rhinitis in Children. Arch Otolaryngol Head Neck Surg. Bd. 134, Nr. 1, S. 67\u201374:2008.\n93 King D, Mitchell B, Williams CP, Spurling GKP. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev, Bd. 4, Art. CD006821:2015.\n94 Pynnonen MA, Mukerji SS, Kim M, Adams ME, Terrell JE. Nasal Saline for Chronic Sinonasal Symptoms: A Randomized Controlled Trial. Arch Otolaryngol Head Neck Surg. Bd. 133, Nr. 11, S. 1115\u20131120:2007.\n95 Ramalingam S, Graham C, Dove J, Morrice L, Sheikh A. A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold. Sci Rep. Bd. 9, Nr. 1, S. 1015:2019.\n96 Hemil\u00e4 H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. Bd. 1, Art. CD000980:2013.\n97 Paul IM, Beiler JS, King TS, Clapp ER, Vallati J, Berlin Jr. CM. Vapor Rub, Petrolatum, and No Treatment for Children With Nocturnal Cough and Cold Symptoms. Pediatrics. Bd. 126, Nr. 6, S. 1092\u20131099:2010.\n98 Jund R, Mondigler M, Steindl H, Stammer H, Stierna P, Bachert C. Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis. Rhinology. Bd. 50, Nr. 4, S. 417\u2013426:2012.\n99 Jund R, Mondigler M, Stammer H, Stierna P, Bachert C. Herbal drug BNO 1016 is safe and effective in the treatment of acute viral rhinosinusitis. Acta Otolaryngol. Bd. 135, Nr. 1, S. 42\u201350:2015.\n100 Gr\u00fcnwald J, Graubaum HJ, Busch R. Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis: A double-blind, randomized, placebo-controlled clinical trial. Drug Res. Bd. 55, Nr. 11, S. 669\u2013676:2005.\n101 Kemmerich B, Eberhardt R, Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough: A prospective, double-blind, placebo-controlled clinical trial. Drug Res. Bd. 56, Nr. 9, S. 652\u2013660:2006.\n102 Gillisen A, Wittig Th, Ehmen M, Krezdom HG, de Mey C. A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol\u00ae forte in acute bronchitis. Drug Res. Bd. 63, Nr. 1, S. 19\u201327:2013.\n103 Bruhn C. Die pflanzliche L\u00f6sung: Saponine und \u00e4therische \u00d6le bei Erk\u00e4ltungshusten und akuter Bronchitis. DAZ. Stuttgart. Nr. 36, S. 40, 07-Sep-2017.\n104 Paul IM, Beiler JS, McMonagle A, Shaffer ML, Duda L, Berlin Jr. CM, Effect of Honey, Dextromethorphan, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents. Arch Pediatr Adolesc Med. Bd. 161, Nr. 12, S. 1140\u20131146:2007.\n105 Goldman RD. Honey for treatment of cough in children. Can Fam Physician. Bd. 60, Nr. 12, S. 1107\u20131110:2014.\n106 Josling P. Preventing the Common Cold With a Garlic Supplement: A Double-Blind, Placebo- Controlled Survey. Adv Therapy. Bd. 18, Nr. 4, S. 189\u2013193:2001.", "language": null, "image": "https://phc.swisshealthweb.ch/fileadmin/_processed_/f/1/csm_PHC_Umschlagbild11_1170x450_de196b9def.jpg", "pagetype": "article", "links": ["https://www.swisshealthweb.ch/de/newsfeed/", "https://phc.swisshealthweb.ch/de/", "#collapseSearch", "/de/article/doi/phc-d.2019.10139/", "/fr/article/doi/phc-f.2019.10139/", "https://www.swisshealthweb.ch/de/newsfeed/", "https://phc.swisshealthweb.ch/de/", "/de/", "/de/aktuelle-ausgabe/", "/de/archiv/", "/de/publizieren/", "/de/ueber-phc/", "https://www.swisshealthweb.ch/de/zeitschriften/", "https://shop.emh.ch/", "https://www.swisshealthweb.ch/de/encyclomed/", "https://events.emh.ch", "https://phc.swisshealthweb.ch/de/article/?tx_cs2services_teaser%5Baction%5D=serviceLinkHandler&tx_cs2services_teaser%5Bcontroller%5D=Services&tx_cs2services_teaser%5Bservice%5D=9&type=96529&cHash=957c22557b087f72957914479c8387b5", "https://jobs.saez.ch/de", "https://market.swisshealthweb.ch/de/", null, "tel:+410614678555", "#", "https://www.swisshealthweb.ch/de/newsfeed/", "/de/article/doi/phc-d.2019.10139/", "/fr/article/doi/phc-f.2019.10139/", "https://events.emh.ch/", "https://jobs.saez.ch/de", "https://market.swisshealthweb.ch/de/", "https://shop.emh.ch/", null, "javascript:void(0)", "https://phc.swisshealthweb.ch/fileadmin/assets/PHC/2019/phc-d.2019.10139/phc-d-2019-10139.pdf", "#otherInfos", "/de/archiv/ausgabe/issue-doi/phc.2019.11/", "https://doi.org/10.4414/phc-d.2019.10139", "javascript:void(0)", "https://phc.swisshealthweb.ch/fileadmin/assets/PHC/2019/phc-d.2019.10139/phc-d-2019-10139.pdf", "https://www.bioforce.ch/de/produkte/arzneimittel/echinaforce_tabletten.php?_ga=2.29882296.605880013.1553503140-1690005440.1548071265", "https://www.kofam.ch/de/studienportal/studie/44496/", "https://smw.ch/fileadmin/content/supplements/SMW_Suppl_228.pdf", "https://www.umckaloabo.ch/de/umckaloabo/pflanzenkraft-statt-antibiotika/", "https://www.pharmazeutische-zeitung.de/ausgabe-082016/pelargonium-bei-atemwegsinfekten/", "https://www.eek.admin.ch/dam/eek/de/dokumente/publikation-und-dokumentation/ausfuehrlicher-expertenbericht-vitamin-d-mangel.pdf.download.pdf/ Vitamin_D_Bericht.pdf", "https://www.ema.europa.eu/en/news/bacterial-lysate-medicines-respiratory-conditions-be-used-only-prevention-recurrent-infections", "https://emh.ch/en/emh/rights-and-licences/", "#top", null, null, "tel:+410614678555", "#", "https://www.swisshealthweb.ch/de/newsfeed/", "https://www.swisshealthweb.ch/de/informationen-und-services/qualitaetssicherung/", "https://www.swisshealthweb.ch/de/informationen-und-services/publizistische-leitlinien/", "https://www.swisshealthweb.ch/de/informationen-und-services/copyright/", "https://www.swisshealthweb.ch/de/informationen-und-services/newsletter/", "https://www.swisshealthweb.ch/de/verlag/ueber-emh/", "https://www.swisshealthweb.ch/de/verlag/inserieren/", "https://www.swisshealthweb.ch/de/verlag/jobs/", "https://www.swisshealthweb.ch/de/partner/", "https://www.swisshealthweb.ch/de/verlag/hilfe-und-kontakt/", "https://www.swisshealthweb.ch/de/agb/", "https://www.swisshealthweb.ch/de/verlag/impressum/", "https://www.swisshealthweb.ch/de/verlag/datenschutz/", "https://www.swisshealthweb.ch/de/verlag/disclaimer/", "javascript:void()"]}